These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 35686735)
1. Design and evaluation of hyaluronic acid-coated PLGA nanoparticles of raloxifene hydrochloride for treatment of breast cancer. Bhatt K; Patil P; Jani P; Thakkar P; Sawant K Drug Dev Ind Pharm; 2021 Dec; 47(12):2013-2024. PubMed ID: 35686735 [TBL] [Abstract][Full Text] [Related]
2. Formulation, optimization and characterization of raloxifene hydrochloride loaded PLGA nanoparticles by using Taguchi design for breast cancer application. Maddiboyina B; Roy H; Nakkala RK; Gandhi S; Kavisri M; Moovendhan M Chem Biol Drug Des; 2023 Sep; 102(3):457-470. PubMed ID: 36856306 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid). Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity. Arvas B; Ucar B; Acar T; Varli HS; Arvas MB; Aydogan F; Yolacan C Nanotechnology; 2024 May; 35(30):. PubMed ID: 38636487 [TBL] [Abstract][Full Text] [Related]
7. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma. Srivastava S; Gupta S; Mohammad S; Ahmad I J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208 [TBL] [Abstract][Full Text] [Related]
8. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation. Mehta AK; Yadav KS; Sawant KK Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492 [TBL] [Abstract][Full Text] [Related]
9. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995 [TBL] [Abstract][Full Text] [Related]
11. Designing and Formulation Optimization of Hyaluronic Acid Conjugated PLGA Nanoparticles of Tamoxifen for Tumor Targeting. Paswan SK; Saini TR; Jahan S; Ganesh N Pharm Nanotechnol; 2021; 9(3):217-235. PubMed ID: 33745427 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors. Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466 [TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients. Derakhshandeh K; Soheili M; Dadashzadeh S; Saghiri R Int J Nanomedicine; 2010 Aug; 5():463-71. PubMed ID: 20957168 [TBL] [Abstract][Full Text] [Related]
14. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy. Gao Z; Li Z; Yan J; Wang P Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710 [TBL] [Abstract][Full Text] [Related]
15. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428 [No Abstract] [Full Text] [Related]
16. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. Ranjan AP; Mukerjee A; Helson L; Vishwanatha JK J Nanobiotechnology; 2012 Aug; 10():38. PubMed ID: 22937885 [TBL] [Abstract][Full Text] [Related]
17. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies. Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818 [TBL] [Abstract][Full Text] [Related]
18. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles. Wu J; Zhang J; Deng C; Meng F; Zhong Z Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935 [TBL] [Abstract][Full Text] [Related]
19. Optimization of Lurasidone HCl-Loaded PLGA Nanoparticles for Intramuscular Delivery: Enhanced Bioavailability, Reduced Dosing Frequency, Pharmacokinetics, and Therapeutic Outcomes. Macwan N; Patel HS; Sharma RK; Jain N; Tandel H Assay Drug Dev Technol; 2024; 22(2):53-62. PubMed ID: 38150562 [No Abstract] [Full Text] [Related]
20. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting. Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]